The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis
The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis
复制标题
雄激素受体基因CAG多态性与多囊卵巢综合征的关联:病例对照研究及荟萃分析
DOI:
10.1007/s10815-014-0286-0
复制
发表时间:
2014-09-01
影响因子:
3.1
通讯作者:
Yin, Jie
中科院分区:
文献类型:
--
作者:
Peng, Cui Ying;Xie, Hui Jun;Yin, Jie
PurposeMany studies have been carried out to confirm the relationship between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome (PCOS), without consistent results. Hence we conducted the current study to research this relationship.Methods224 Chinese Han women with PCOS and 223 in vitro fertilization and embryo transplantation (IVF-ET) infertile women with tubal factor or male infertility served as the controls were recruited in our study. PCR-based assays were applied to genotype the (CAG)nrepeat alleles. A meta-analysis including 1,536 PCOS patients and 1,807 controls was conducted to produce a pooled estimate.ResultsWe observed that the CAG bi-allelic mean lengths were similar in PCOS patients and controls (22.65 ± 2.5 vs. 23.09 ± 2.1,P= 0.116). When CAG bi-allelic were divided into two categories (mean repeats ≤22, >22), the short AR-CAG bi-allelic showed more frequent in PCOS group than in controls (56.25 % vs 29.14 %,P< 0.001). Further analysis presented that, in PCOS, there was a lower mean CAG repeat lengths in mean bi-allelic lengths (22.3 ± 2.5 vs. 23.9 ± 2.2,P= 0.008) and long bi-allelic lengths (24.3 ± 1.4 vs. 25.9 ± 1.6,P= 0.05) among patients with testosterone less than 0.7 ng/ml compared with those whose testosterone was more than 0.7 ng/ml. Besides, the testosterone were positively correlated with the CAG polymorphism (r= 0.237,P= 0.008), which accorded with our meta-analysis results.ConclusionsThe distribution of AR-CAG allele differed between PCOS patients and controls, and polymorphism of CAG repeat lengths may contribute to hyperandrogenism in PCOS.